UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026008
Receipt number R000029858
Scientific Title Effect of amino acids intake on post-exercise gastrointestinal function
Date of disclosure of the study information 2022/01/01
Last modified on 2022/10/23 13:11:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of amino acids intake on post-exercise gastrointestinal function

Acronym

Effect of amino acids intake on post-exercise gastrointestinal function

Scientific Title

Effect of amino acids intake on post-exercise gastrointestinal function

Scientific Title:Acronym

Effect of amino acids intake on post-exercise gastrointestinal function

Region

Japan


Condition

Condition

Healthy

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy of amino acids intake on post-exercise gastrointestinal dysfunction

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Gastrointestinal function / Prevention

Key secondary outcomes

Inflammatory response / Suppression


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Amino acids intake,Exercise loading, Measurements of gastrointestinal function and inflammatory response, Three-weeks washout, Placebo intake, Exercise loading, Measurements of gastrointestinal function and inflammatory response

Interventions/Control_2

Placebo intake, Exercise loading, Measurements of gastrointestinal function and inflammatory response, Three-weeks washout, Amino acids intake, Exercise loading, Measurements of gastrointestinal function and inflammatory response

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >=

Gender

Male

Key inclusion criteria

1. Healthy adult
2. A subject who can participate in exercise loading
3. A subject who can provide written informed consent

Key exclusion criteria

1. Any subject who has external injury or medical disease
2. Any subject who has a gastrointestinal disorder
3. Any subject who takes NSAIDs
4. Any subject who had 200 mL or more of blood taken within the past 12 weeks
5. Any subject who has a history of diabetes or blood sugar abnormality
6. Any subject who has a BMI of 25 or higher
7. Any subject who has a known allergy to food containing sugar alcohol or lactulose
8. Any subject who is considered as inappropriate for participating into the study at the judgement of principal investigator

Target sample size

16


Research contact person

Name of lead principal investigator

1st name Katsuhiko
Middle name
Last name Suzuki

Organization

Waseda University

Division name

Faculty of Sport Sciences

Zip code

359-1192

Address

2-579-15, Mikajima, Tokorozawa-shi, Saitama

TEL

04-2947-6898

Email

katsu.suzu@waseda.jp


Public contact

Name of contact person

1st name Miho
Middle name
Last name Ono

Organization

Ajinomoto Co., Inc

Division name

Human health & nutrition group, Institute of food sciences & technologies

Zip code

210-8681

Address

1-1, Suzuki-cho, Kawasaki-ku, Kawasaki-shi

TEL

044-223-4114

Homepage URL


Email

miho_ono@ajinomoto.com


Sponsor or person

Institute

Waseda University, Faculty of Sport Sciences

Institute

Department

Personal name



Funding Source

Organization

Ajinomoto Co., Inc

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Waseda University

Address

1-104 Totsuka-machi, Synjyuku-Ku, Tokyo

Tel

03-5272-1639

Email

rinri@list.waseda.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

早稲田大学(埼玉県)


Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 01 Month 24 Day

Date of IRB

2017 Year 02 Month 06 Day

Anticipated trial start date

2017 Year 03 Month 01 Day

Last follow-up date

2022 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 02 Month 06 Day

Last modified on

2022 Year 10 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029858